Is Chamomile Sleep Onset Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Chamomile Sleep Onset Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Compared to baseline values, consumption of CTT significantly reduced ( p < 0.001) visual analog scale and numerical rating scale values by 57.17% and 55.46%, respectively. [Soh Z (2025); evidence level 2] - Meanwhile, non-CTT consumption significantly reduced ( p < 0.05) the severity of complexation, neuroticism, and confusion in the control group. [Soh Z (2025); evidence level 2] - This study aimed to evaluate the effects of chamomile and 1-theanine beverage intake on menstrual symptoms, pain intensity, mood, and sleep quality in young adult females with primary dysmenorrhea, using a two-phase continuous study design. [Soh Z (2025); evidence level 2] - In the first phase, a cross-sectional study was conducted to assess the prevalence of primary dysmenorrhea. [Soh Z (2025); evidence level 2] - Failure to meet the recommended 7-9 hours of restful sleep per night is known to increase the risk of several health conditions, reason why regular and adequate sleep should be seen as a priority instead of an unnecessary commodity easily traded as required by the commitments of our busy lives. [Conti F (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.